跳至主要内容
临床试验/NCT03895138
NCT03895138Unknown不适用

A Feasibility Randomized Control Trial to Investigate the in Silico Optimization of Insulin Treatments

University of Virginia2 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2018年3月19日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
35
试验地点
2
主要终点
Exposure to risk of hypoglycemia

研究概览

简要总结

The primary objective of this study is to assess the performance of an in silico designed alternative protocol for control of stress hyperglycemia of inpatients treated for Coronary Artery Bypass Graft (CABG) or valve replacement surgery in the University of Virginia cardiothoracic ICU.

详细描述

The hypothesis of the study is that settings for the Glucommander protocol can be optimized in silico to achieve statistically improved low blood glucose index (LBGI) within the subpopulation of CABG and valve replacement patients who both receive Glucommander-based insulin therapy and meet Manufacturer's guidelines for starting with an initial multiplier value of .052, without risking clinically significant increase in exposure to hyperglycemia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
40 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients admitted for CABG and/or open heart valve surgery
  • Must have a 0.05 initial multiplier setting for the Glucommander based on the manufacturers recommendations
  • Age of 40-75, inclusive

排除标准

  • History of severe hypoglycemia within six months of hospital admission
  • Currently undergoing dialysis or renal replacement therapy
  • Women of childbearing potential
  • Patients with endocarditis needing valve replacement
  • Participation in another clinical trial at the time of screening.

研究组 & 干预措施

Optimized Glucommander (OGM)

Experimental

CABG or open valve surgery patients treated for stress hyperglycemia with in silico optimized Glucomander protocol

干预措施: Optimized Glucommander (OGM) (Other)

Standard Glucommander Protocol (SGP)

Active Comparator

CABG or open valve surgery patients treated for stress hyperglycemia with the standard Glucomander protocol according to the manufacturer recommendations

干预措施: Standard Glucommander Protocol (SGP) (Other)

结局指标

主要结局

Exposure to risk of hypoglycemia

时间窗: 24 hours of post-operative hospital stay

Exposure to risk of hypoglycemia as measured by the Low Blood Glucose Index (LBGI).

次要结局

  • Exposure to risk of hypoglycemia(48 hours of post-operative hospital stay)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Anthony McCall

Principal Investigator

University of Virginia

研究点 (2)

Loading locations...

相似试验